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 Abstract 
For my senior project, I perform data analysis using statistical methods to determine body metrics that 
correlate with blood glucose levels. Working with Dr. Tina Smilkstein, I take repeat measurements from 6 
different volunteers to establish trends in bodily metric data. The data taken includes weight, body fat, 
pulse rate, VO2, blood glucose, blood pressure, hours slept, and quality of sleep. Using these values, I use 
the program MiniTab to view results. 
 
A few examples of correlations with blood glucose found in this project are: 
• Systolic blood pressure for females had a regression line of 124.0 -0.3366*Blood Pressure. This 
indicates a negative correlation, meaning as blood pressure rose, blood glucose dropped. For 
males, the line equation is 59.47 + 0.2962*Blood Pressure, indicating a positive correlation. 
• In the case of diastolic blood pressure, male data was quite scattered graphically, indicating the 
line of best fit is not an accurate representation of blood glucose. For females, the line is 111.9 – 
0.3565*Blood Pressure (diastolic). This again indicates a negative correlation. 
• In the case of weight, both lines graphically followed the data points. For males, the regression 
line is 162.6 – 0.342*Weight. For females, it is 103.2- 0.1525*Weight. 
• The rest of the correlations and data is found in the contents of the report.  
 
Leveraging the results of this research, patients can potentially input their information into a webpage that 
predicts whether or not they must prick their finger to view actual blood glucose. While this tool may 
provide an interesting learning opportunity, the numerical value provided is not meant to be taken as 
medical advice. Every individual has different bodily metrics, therefore the value given is for 
experimentation, not for a 100% accurate measurement. To be sure of your blood glucose, until the 
technology has improved, always use a Blood Glucose Monitor, since I am not a medical professional. 
Once perfected, this could lead to saved time, pain, and trouble for the user. For the following data, it 
reflects 18-24 year old college students without diabetes to establish a baseline.  
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Chapter 1. Introduction 
Using bodily metrics to understand changes in blood glucose and even predict it, my senior 
project, implements research to anticipate a patient’s blood glucose levels without puncturing their skin, a 
common customer grievance. This research can be leveraged to determine important trends. These trends 
may be used to create, potentially, a non-invasive blood glucose monitor. The monitor would measure the 
metrics other than blood glucose, allowing a pain-free blood glucose prediction method. The product’s 
customers, diabetics or pre-diabetics, can now predict their insulin needs more easily. This project allows 
patients to keep a closer eye on their health, without causing unnecessary pain, discomfort, and cost for 
doing so. Some blood glucose testing strips cost as much as $1.50 per strip. With testing every time you 
eat, this cost could grow over $5 a day. Although this tool is interesting to use, it is in the early stages of 
research and should not be taken as medical advice. 
 The project’s context is a time of changing and quickly advancing medical devices. The biotech 
industry continuously advances, with blood glucose monitors constantly needing attention [7]. These 
updates make them smaller, faster, more comfortable, and more user accessible.  However, not many of 
these methods lack a needle pricking the skin of the user [6]. This project adds that layer of customer 
compatibility to the market, making it the prime choice for those not wishing to repeatedly puncture 
themselves. 
 Other researchers have explored similar paths, but by using statistics to explore complex trends 
and make sense of obscure values, the data becomes much more useful. The need for a blood glucose 
prediction method improving patient life quality makes all work done completely necessary. A product 
not requiring breaking the skin of patients could revolutionize the blood-glucose monitoring industry, 
allowing millions of patients the option to reduce a daily annoyance and physical pain of pricking 
themselves to achieve life-saving data. To provide an example, diagnosed type 2 diabetes in the United 
States in 2016 totaled at 21 million people. This doesn’t include those with pre-diabetes or undiagnosed 
individuals. Some diabetics check their blood glucose up to seven times a day. Total pricks per day, just 
in the United States, is 147 million pricks. This leads to over $150 million spent by Americans every day 
in the United States. Imagine half of those pricks could be avoided by checking pulse, blood pressure, or 
other metrics. Many moments of pain and discomfort can be avoided, as well as nearly $75 million. 
 
 
Chapter 2. Customer Needs, Requirements, and Specifications 
Customer Needs Assessment 
The target customers of this product, diabetes patients, need a method featuring the following: 
• Simple – the measurements taken and webpage used to calculate should be intuitive 
• Non-invasive – the device provides an external-only solution 
• Reliable – the customer can trust the prediction made, but not accept it as medical advice 
• Private – customers’ data does not remain in system beyond their calculation 
 
Requirements and Specifications 
The requirements and specifications of this project arose from discussion and revision of original plans 
for the project. Inspiration for many of the specifications came from existing products and what the 
companies advertise as their most lucrative features. [1] [4] 
 
Subject Selection 
In order to choose subjects, the candidates must meet several criteria in the selection process and 
measurement process. For example: 
• Subjects must not take blood thinners or other medications that interfere with the safety or results. 
• Subject’s ages range from 18-24 years old. 
• The testing will not impede any costs upon the subjects. 
• Preparation for the data collection includes only cleaning the surface of the skin and ensuring the 
subject is seated and relaxed.  
• The subjects do not experience excessive pain or discomfort during data collection. 
• The data is available to subjects at time of collection, and is anonymous. 
 
 
 
TABLE IV 
WEARABLE ADHESIVE CIRCUIT DELIVERABLES 
Step Delivery Date Deliverable Description 
1 4/15/2019 Design Review  
2 5/23/2019 EE 461 demo 
3 5/6/2019 EE 461 report 
4 11/21/2019 EE 462 demo 
5 2/18/2019 ABET Sr. Project Analysis 
6 12/31/2019 EE 462 Report 
[1] R. Ford and C. Coulston, Design for Electrical and Computer Engineers, McGraw-Hill, 2007, p. 37 
[2] IEEE Std 1233, 1998 Edition, p.  
 
 
1. The first step, design review, was done in the EE460 course at Cal Poly, SLO. This included the 
formatting of this report in early stages, involving section creation.  Dr. David Braun oversaw this 
process. Once complete, the report is handed to the advisor, Dr. Tina Smilkstein, who provides 
project feedback. This concludes the design review. 
2. The EE 461 demo does not apply for this project, but it consisted of finishing research, gathering 
all materials, and preparing for data collection with subjects. This continued into the summer, 
where I took weeks of data on myself to perfect the methods and ensure the data taken on subjects 
was done quickly and safely. 
3. Similar to the EE460 design review, EE461 also requires an update to the advisor on report status 
with any new information. 
4. The EE 462 demonstration involved setting up the calculator to predict blood glucose with the 
regression analysis with the lowest P-values. This was inputted into the calculator-building 
website, then presented to Dr. Smilkstein to use and explore. The information for this calculator 
was found through several months of data collection from multiple subjects, then compiled and 
analyzed using Excel and Minitab. A more detailed time-flow of the project is found below: 
a. First, determining which types of data to take and doing research on current blood 
glucose measurement techniques. 
b. Second, gathering subjects for data collection. 
c. Third, gathering data from the subjects, including at least three measurements from each 
person first thing in the morning.  
d. Fourth, analyzing the data through MiniTab to see which metrics were the most 
significant and which could be disregarded. 
e. Last, creating a tool for people to use and easily interpret my findings. 
5. The ABET Sr. Project Analysis, a required portion of an Electrical Engineering senior project, 
was completed in EE460, but redone for the EE462 final report to represent the actual project 
once completed, instead of the theoretical project designed in EE460. 
6. The EE462 report, this document, includes the data compiled and analyzed using MiniTab 19. 
This software allowed me to create linear regression graphs, create regression equations, and 
view coefficients to explain the accuracy of predictions. These visual and numerical analyses are 
found within this report. To submit this report, it is uploaded to the digital commons of the Cal 
Poly library, and approved by the advisor. 
7. Results of Statistical Analysis  
The results of this research showed interesting correlations. Notably, the differences between the male 
and female trends. At first, I analyzed both sexes together. Out of curiosity, I decided to split up male and 
female results, showing very interesting data. As a disclaimer, these results always may be a coincidence 
for the individuals I tested. Additionally, more subjects, more measurements, and a longer and more 
controlled study would improve the trends analyzed in this project. 
 
Figure 2: Blood glucose compared with diastolic blood pressure data.  
It became clear that the data taken on females was more indicative of accurate predictions. The reason for 
this remains unclear. In Figure 2, we see that generally, male blood glucose rises with diastolic blood 
pressure, as expected. However, female blood glucose consistently fell as blood pressure increased. This 
may have something to do with stress, exercise, and hormones. The regression equations used are seen 
below. Then, the coefficients show that at a 22.7% P-value indicates that diastolic blood pressure alone is 
not enough for an accurate prediction of blood glucose. 
Regression Equation 
M/F    
F Blood Glucose = 102.7 - 0.239 Blood pressure (dia) 
        
M Blood Glucose = 116.8 - 0.239 Blood pressure (dia) 
Coefficients 
Term Coef SE Coef T-Value P-Value VIF 
Constant 102.7 15.0 6.84 0.000   
Blood pressure (dia) -0.239 0.190 -1.26 0.227 1.00 
M/F           
  M 14.11 3.80 3.72 0.002 1.00 
 
 Figure 3: Systolic blood pressure and blood glucose associations. 
In Figure 3, the trends follow a similar pattern as Figure 2. Again, the female blood glucose fell as blood 
pressure rose, while the male data remained more scattered. This may be due to statistical outliers, stress, 
or simply a more consistent trend in female measurements. The actual regression equations for male and 
female results are seen below. While graphically, systollic blood presure looks like a good indicator, the 
coefficients reveal that when used alone, it is not sufficient to predict blood glucose.  
Regression Equation 
M/F    
F Blood Glucose = 103.0 - 0.159 Blood pressure (sys) 
        
M Blood Glucose = 118.9 - 0.159 Blood pressure (sys) 
 
Coefficients 
Term Coef SE Coef T-Value P-Value VIF 
Constant 103.0 22.6 4.56 0.000   
Blood pressure 
(sys) 
-
0.159 
0.189 -0.84 0.412 1.33 
M/F           
  M 15.88 4.48 3.54 0.003 1.33 
  
 
Figure 4: Blood glucose trends with weight differing between male and female subjects. 
In Figure 4, interestingly enough, trends defy expectations. As weight went up, blood glucose when 
down. Since all subjects are moderately active 18-24 year olds, I believe their muscle mass may have 
caused this phenomenon. Generally, resistance exercise increases muscle mass as well as lowing blood 
glucose levels [18].  The male weight correlation contains a higher variety of inputs than female, since 
most female data lies from 150-160 lbs.  
The regression fit formula of the male correlation line is Blood Glucose = 162.6 - .3420*Weight. This 
formula may be used to predict blood glucose based of weight alone for men in the correct age/activity 
range.  
 
 
 
 
 
Regression Equation 
M/F    
F Blood 
Glucose 
= 103.2 -
 0.153 Weight 
        
M Blood 
Glucose 
= 162.6 -
 0.342 Weight 
 
The regression equation above shows how to predict blood glucose between males and 
females. It is important to categorize sexes since, as seen above, the equations are quite 
different.  
Coefficients 
Term Coef SE Coef T-Value P-Value VIF 
Constant 103.2 27.5 3.75 0.003   
Weight -0.153 0.189 -0.81 0.437 9.69 
M/F           
  M 59.3 35.3 1.68 0.121 108.50 
Weight*M/F           
  M -0.190 0.222 -0.85 0.412 156.98 
The coefficients of the regression equation explain the statistical significance of the data.  
 
 
 Figure 5: Blood glucose trends analyzed with respect to body fat percentage. 
Figure 5 shows that there was very little correlation between blood glucose and body fat percentage. 
Some may be seen for males, but the scattered points may not be indicitave of a strong relationship. 
Overall, there was a slight downward trend in male blood glucose as body fat increased. For females, 
body fat had no correlation with blood glucose, as over a wide range of body fats, blood glucose stayed 
relatively constant. 
MiniTab, the software used for the figures in this report, also has the ability to make predictions. Using a 
regression equation and weighting the male/female categories, Minitab provides an estimation of blood 
glucose level. For the calculator I created, I used a slightly different method by splitting up the male and 
female equations. 
Below are several inputs and outputs of this estimation.  
Case 1: Blood pressure and sex 
Case 1 represents only blood pressure (diastolic and systolic) and sex as factors in the prediction. I chose 
these metrics since from Figure 3, we found that blood pressure, especially in males, led to a low P-value 
(likelyhood the prediction is wrong) when predicting blood glucose. 
 
 
Regression Equation 
Blood Glucose = 107.2 + 0.089 Blood pressure (sys) - 0.433 Blood pressure (dia) 
+ 0.000000 M/F_F - 78.7 M/F_M + 0.000000 Blood pressure 
(sys)*M/F_F 
+ 0.142 Blood pressure (sys)*M/F_M + 0.000000 Blood pressure 
(dia)*M/F_F 
+ 0.937 Blood pressure (dia)*M/F_M 
 
Settings 
Variable Setting 
Blood pressure (sys) 126 
Blood pressure (dia) 70 
M/F F 
 
Prediction 
Fit SE Fit 95% CI 95% PI  
88.1743 8.31166 (70.2180, 
106.131) 
(62.9093, 
113.439) 
X 
X denotes an unusual point relative to predictor levels used to fit the model. 
Case 2: Pulse, weight, blood pressure, and sex 
Case 2 represents pulse, weight, blood pressure, and sex as factors in the prediction. I chose these metrics 
for a more complete prediciton than in Case 1, while excluding metrics with extremely high P-values or 
that had clearly no correlation, graphically. Several different inputs are used to represent varying types of 
subjects. 
 
 
Regression Equation 
Blood 
Glucose 
= 111.5 + 0.055 Pulse Rate - 0.299 Weight - 0.056 Blood 
pressure (sys) 
+ 0.177 Blood pressure (dia) + 0.000000 M/F_F 
+ 32.53 M/F_M 
 
 
 
Input 1: 
Settings 
Variable Setting 
Pulse Rate 80 
Weight 150 
Blood pressure (sys) 120 
Blood pressure (dia) 70 
M/F F 
Prediction 
Fit SE Fit 95% CI 95% PI 
76.7930 4.90026 (65.7078, 87.8781) (56.9951, 96.5908) 
Input 2: 
Settings 
Variable Setting 
Pulse Rate 55 
Weight 200 
Blood pressure (sys) 110 
Blood pressure (dia) 75 
M/F M 
 
Prediction 
Fit SE Fit 95% CI 95% PI 
94.4555 6.18656 (80.4606, 108.451) (72.8932, 116.018) 
Input 3: 
Settings 
Variable Setting 
Pulse Rate 95 
Weight 135 
Blood pressure (sys) 105 
Blood pressure (dia) 65 
M/F F 
 
 
Prediction 
Fit SE Fit 95% CI 95% PI  
82.0487 7.35639 (65.4074, 98.6900) (58.6819, 105.416) X 
X denotes an unusual point relative to predictor levels used to fit the model. 
 
Input 4: 
Settings 
Variable Setting 
Pulse Rate 85 
Weight 181 
Blood pressure (sys) 135 
Blood pressure (dia) 85 
M/F M 
Prediction 
Fit SE Fit 95% CI 95% PI 
102.166 3.74881 (93.6855, 110.646) (83.6999, 120.632) 
 
 
The predictions above show interesting trends in the data when compared. All predictions were 
within a realistic boundary of blood glucose levels for this age group. Interesting differences 
would be when changing two variables and seeing how the blood glucose prediction changed 
and which trend it follows, showing which variable is more indicative of blood glucose level. 
An example of this would be Case 2, Input 1 and 3. Both are female predictions. Pulse was 
increased, but weight decreased. Blood glucose still increased, even though a decrease in weight 
indicated a lower blood glucose from the trends. This indicates that pulse is a stronger predictor 
in this case.  
Conclusion 
This project aims to reduce the number of times a person must prick themselves. To begin the 
lengthy process of determining the best and most accurate way to do this, my project uses data 
collected on 18-24 year old college students without diabetes, to first understand the baseline of 
healthy blood glucose. From this data, further research can be done to determine abnormalities 
and eventually leverage the information into a device. The goal of this project was reached, with 
finding which metrics were most helpful in determining blood glucose. Body fat, VO2, sleep 
quality, and sleep length (short term) were ruled out, while weight, pulse, blood pressure, and 
sex were found to be significant. 
Along with data found, anyone with an internet connection can now roughly predict their blood 
glucose. It is important to note that this is not medical advice and I am not a doctor, simply a 
researcher. The calculator is found here: https://www.calconic.com/calculator-widgets/blood-
glucose-predictor/5dcf37d8893823001e8a7b7c. 
In the future, this calculator could be used in a non-invasive blood glucose measuring device. 
By using other metrics, the needle pricking the user’s skin becomes unnecessary. The goal of 
this project was to begin the process of eliminating metrics that did not predict blood glucose or 
had no significant correlation.  
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Appendix A. Senior Project Analysis 
TABLE V 
APPENDIX D — ANALYSIS OF SENIOR PROJECT DESIGN 
Please provide the following information regarding your Senior Project and submit to your advisor 
along with your final report. Attach additional sheets, for your response to the questions below. 
Project Title: Blood Glucose Predicting Algorithm 
Student’s Name: Jessica Patterson Student’s Signature: 
Advisor’s Name: Tina Smilkstein Advisor’s Initials: Date:  
• 1. Summary of Functional Requirements  
This easy-to-use, non-invasive method of predicting blood glucose allows users to understand their 
bodily metrics better. It exists as a free calculator website to ensure accessibility.  
• 2. Primary Constraints  
Measuring accurate propagation delay of the signal may be a significant challenge, as several factors 
can influence this time measurement. The accuracy of the printed transistors also may affect the 
functionality of the monitor. The difficulty of finding subjects affects the timeline of this project. 
Many limiting factors affect this project, such as time, test subject availability, and 
accuracy/availability of data. 
What made your project difficult? What parameters or specifications limited your options or directed 
your approach?  
Finding and getting subjects to do repeat measurements was the most difficult part of this project. Resources for analysis 
were available to me, but driving around to different subjects houses to make it easier for them was time-consuming. 
• 3. Economic 
• What economic impacts result? Consider: 
   Human Capital – Humans may not possess the knowledge of how the calculator works, leading to 
disbelief in the effectiveness. 
   Financial Capital – Patients may not have the money to try this calculator on a computer, forcing 
them to continue using the painful finger-prick method. 
   Natural Capital – The use of internet increases energy consumption. 
• Costs and benefits accrue after the calculator has been implemented to a limited number of test 
subjects to ensure safety and effectiveness. It may take many design-build-test iterations before the 
product proves suitable for the general population if the calculator is leveraged into a device. 
 
   Original estimated cost of component parts: $500.00 
   Actual final cost of component parts (at the end of your project): $12.00 to me, about 500 total 
including parts provided by Dr. Smilkstein. 
   Attach a final bill of materials for all components.  
   Additional equipment costs include shipping costs, compensation for test subjects, and additional 
work hours of the engineer once made into a device. 
• How much does the project earn? Who profits? 
As of now, the project earns no money. It is a free-to-use calculator to make medical testing more 
accessible.  
 
• Timing  
   When do products emerge? How long do products exist? What maintenance or operation costs 
exist? 
The calculator emerges immediately. If made in to a device, products emerge 3-7 years after creation 
due to the need to complete the FDA device approval process [15]. Product lifetime remains 
unknown until test subjects can confirm functionality.  
 
   Original estimated development time (as of the start of your project), as Gantt or Pert chart: 26 
weeks. 
   Actual development time (at the end of your project), as Gantt or Pert chart: 27 weeks. 
After the project ends, others may implement the ideas laid out in this senior project plan to bring the 
product to market. 
• 4. If manufactured on a commercial basis:  
N/A 
• 5. Environmental 
• Describe any environmental impacts associated with manufacturing or use, explain where they 
occur and quantify. 
While usage of the calculator does not pose environmental threats, the manufacturing of the device 
may release pollutants, depending on the factory’s conditions. Pollution from shipping vehicles also 
poses an environmental concern, from large-scale shipping of materials to small-scale shipping to 
customers. This likely does not compare with the current pollution levels from large companies. The 
device manufacturing can likely take place in an existing factory and share shipping with other 
relevant medical devices, reducing the impact. 
• Which natural resources and ecosystem services does the project use directly and indirectly? 
If made into a product, this item directly uses water and oxygen in the production process for 
machinery and uses plant materials when producing the substrate cloth. The product indirectly uses 
habitats for animals through deforestation to achieve plant materials to produce paper for user 
manuals. 
 
• Which natural resources and ecosystem services does the project improve or harm? 
This project improves the quantity of paper due to the reduced need for blood testing strips and 
plastic materials to create the testing devices. It harms the atmosphere through vehicle exhaust 
shipping and transportation. 
 
• How does the project impact other species? 
This project impacts other species indirectly by taking natural resources such as water and trees, 
leading to habitat reduction. 
• 6. Manufacturability 
   Manufacturing difficulties may include finding a location for manufacturing, paying for the 
necessary materials and space for large scale production, and surpassing legal barriers for 
manufacturing. 
• 7. Sustainability 
• Describe any issues or challenges associated with maintaining the completed device, or system. 
If the device does not last as long as intended, production costs may increase to an unsustainable 
amount. In addition, customers may choose not to purchase the device more than once if it does not 
last. 
 
• Describe how the project impacts the sustainable use of resources. 
The project reduces the use of paper test strips and reduces the need for multiple devices through the 
ability to recharge and reuse the device. 
 
• Describe any upgrades that would improve the design of the project. 
To upgrade the concept, a manufacturer could add functionality such as heart rate monitoring, drug 
level monitoring, and devise a plan for insulin depositing. 
 
• Describe any issues or challenges associated with upgrading the design. 
The requirement that the device does not need to prick the user causes an issue with adding insulin 
depositing functionality  
• 8. Ethical 
   Describe ethical implications relating to the design, manufacture, use, or misuse of the project. 
Analyze using one or more ethical frameworks in addition to the IEEE Code of Ethics. 
The first ethical framework of the IEEE Code of Ethics states: 
“to hold paramount the safety, health, and welfare of the public, to strive to comply with ethical design and 
sustainable development practices, and to disclose promptly factors that might endanger the public or the 
environment” 
The desire to provide a device related to the health of those with diabetes upholds the ideals of this 
code. 
The fifth ethical framework states: 
“to improve the understanding by individuals and society of the capabilities and societal implications of 
conventional and emerging technologies, including intelligent systems” 
The desire to reduce pain involved with glucose monitoring ensures that the project understands the 
complaints of society and strives to provide an alternative method.  
The misuse of this product does not cause problems, since the only functionality provides blood 
glucose monitoring, which likely does not involve sinister intentions. 
• 9. Health and Safety 
   Describe any health and safety concerns associated with design, manufacture or use of the project. 
The application of current to the human body may concern some users. However, the amount of 
current used does not harm the user as long as they do not have any electrical components already 
inside them, such as a pacemaker. 
• 10. Social and Political 
• Describe social and political issues associated with design, manufacture, and use. 
The rigorous and lengthy FDA approval process may cause an issue with bringing the product to 
market. However, this process ensures the upmost quality of the device. 
 
• Who does the project impact? Who are the direct and indirect stakeholders? 
This project effects manufacturers of materials, patients with diabetes, doctors, competitors, and 
investors. It directly effects engineers and patients. 
 
• How does the project benefit or harm various stakeholders? 
The project benefits those earning a profit or receiving important data from the product, such as 
engineers, shipping companies, material manufacturers, and patients. However, competing 
companies may endure financial harm if their products lose popularity. 
 
• To what extent do stakeholders benefit equally? Pay equally? Does the project create any 
inequities? 
Engineers and investors likely earn much more than shipping contractors and materials 
manufacturers. However, due to decreased involvement by the latter, this difference in pay does not 
cause concern. 
 
• Consider various stakeholders’ locations, communities, access to resources, economic power, 
knowledge, skills, and political power. 
The access to resources may affect the benefits of the patients, depending on whether or not they live 
in a developed country, have access to electricity, earn an income, and more. These people have 
unfair limitations placed on them and may not receive the product at any point. 
• 11. Development 
   Describe any new tools or techniques, used for either development or analysis you learned 
independently during the project’s course.  
Please see page 9’s bibliography. 
Through this literature search, I learned about marketing medical devices, common medical device 
specifications, and the various blood glucose monitoring methods currently on the market. 
Apendix B. Project Planning 
 
EE 460 Gantt Chart for Winter Quarter, 2019 listing recommended work periods (green lines), 
due dates (blue triangles), and when the project requires feedback (circle of arrows).  
 
EE 461 Gantt Chart for Spring Quarter, 2019 including work periods and due dates for design, 
test, and build cycles. 
 
EE 462 Gantt Chart for Fall Quarter, 2019 including work periods and due dates for the final 
design, test, and build cycles. This also includes the senior project expo and conclusion of the 
project.  
 
